Elanix Biotechnologies develops and commercializes tissue regeneration products for chronic and acute wound care, and advanced skin care products for dermatological and gynaecological applications.
Our technology is the result of 30 years of progenitor cell research and development by Prof. Lee Ann Laurent-Applegate and her team at the University Hospital of Lausanne (CHUV).
The Company is headquartered in Berlin, Germany with offices in Nyon, Switzerland and Wiesbaden, Germany, and listed on the Frankfurt stock exchange under the symbol ELN.
Company Details
- Founded
- -
- Address
- Chemin Du Joran, 10,switzerland
- Phone
- 41225520971
- in****@****anix.ch
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Biotechnology, Regenerative Medicine, Advanced Wound Care, Advanced Skin Care, Progenitor Cell Therapy.
- HQ
- Nyon, Vaud
Elanix Biotechnologies Sa Questions
Elanix Biotechnologies Sa's helpline number is 41225520971
Elanix Biotechnologies Sa's website is http://www.elanixbiotechnologies.com
Elanix Biotechnologies Sa's LinkedIn profile is https://ch.linkedin.com/company/elanix-biotechnologies-sa
Elanix Biotechnologies Sa's industry is
Biotechnology Research
Elanix Biotechnologies Sa's top competitors are
Hartis Pharma,
Aginko Foundation,
Mpx International Corporation,
Haya Therapeutics,
Nd Biosciences,
Lbvpam - Laboratory Of Plant Biotechnologies Applied To Aromatic And Medicinal Plants,
Edge Biotechnologies,
Iqone Healthcare Switzerland,
Eli Lilly And Company,
Effik Suisse.
Elanix Biotechnologies Sa's support email address is info@elanix.ch
Elanix Biotechnologies Sa's categories are Biotechnology Research
Elanix Biotechnologies Sa's founding year is 2012
